RECRUITING

Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is an observation study using the Flashback CRI T1 tablet to collect data on compensatory reserve index in pediatric trauma patients. Highest trauma activations at the institution will be enrolled in the study and data will be collected for 12-24 hours based on the patient's hemodynamic status. The device collects data via a pulse oximeter probe. No treatment decisions will be made based on the values of the on the CRI tablet. Data will be retrospectively reviewed to determine if any trends exist that correlate with blood loss, need for operation or blood transfusion.

Official Title

Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients

Quick Facts

Study Start:2021-05-01
Study Completion:2024-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04911465

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:31 Days to 26 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Pregnant patients
  2. * Incarcerated patients
  3. * Patients who object to study participation at any time
  4. * Limited access to or compromised monitoring sites for non-invasive finger sensors
  5. * Brain death (GCS 3 with fixed, dilated pupils)

Contacts and Locations

Study Contact

Marina Reppucci, MD
CONTACT
7207775371
marina.reppucci@childrenscolorado.org

Principal Investigator

Steven L Moulton, MD
PRINCIPAL_INVESTIGATOR
Children's Hospital Colorado

Study Locations (Sites)

Children's Hospital Colorado
Aurora, Colorado, 80045
United States
Children's National Hospital
Washington, District of Columbia, 20010
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Steven L Moulton, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital Colorado

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-05-01
Study Completion Date2024-06-30

Study Record Updates

Study Start Date2021-05-01
Study Completion Date2024-06-30

Terms related to this study

Keywords Provided by Researchers

  • Pediatric

Additional Relevant MeSH Terms

  • Trauma